Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study
暂无分享,去创建一个
Paul Cumming | Hans-Georg Buchholz | Andreas Heinz | Peter Bartenstein | Ingo Vernaleken | Thomas Siessmeier | Gerhard Gründer | Yoshitaka Kumakura | Thorsten Kienast | A. Heinz | P. Cumming | H. Buchholz | G. Gründer | I. Vernaleken | Y. Kumakura | T. Siessmeier | T. Kienast | P. Bartenstein
[1] Albert Gjedde,et al. The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms , 1997, Journal of Neuroscience Methods.
[2] Doris J. Doudet,et al. In Vivo Receptor Assay with Multiple Ligand Concentrations: An Equilibrium Approach , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] P. Cumming,et al. Kinetics of the metabolism of four PET radioligands in living minipigs. , 2001, Nuclear medicine and biology.
[4] Albert Gjedde,et al. PET Studies of Net Blood—Brain Clearance of FDOPA to Human Brain: Age-Dependent Decline of [18F]Fluorodopamine Storage Capacity , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] Alan C. Evans,et al. Dopa decarboxylase activity of the living human brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] D. Doudet,et al. Loss of metabolites from monkey striatum during PET with FDOPA , 2001, Synapse.
[8] Alan C. Evans,et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[10] Alan C. Evans,et al. Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] O. Wolkowitz,et al. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid. , 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[12] Scott T. Grafton,et al. Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] A. Gjedde,et al. Effect of catechol‐O‐methyltransferase inhibition on brain uptake of [18F]fluorodopa: Implications for compartmental modelling and clinical usefulness , 1998, Synapse.
[14] G. Heninger,et al. Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. , 1969, International journal of neuropharmacology.
[15] J. Hietala,et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients , 1995, The Lancet.
[16] A. Gjedde,et al. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms , 1998, Synapse.
[17] Albert Gjedde,et al. Dopamine Storage Capacity in Caudate and Putamen of Patients with Early Parkinson's Disease: Correlation with Asymmetry of Motor Symptoms , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] J. Mazziotta,et al. Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.
[19] Anthony A. Grace,et al. Regulation of conditioned responses of basolateral amygdala neurons , 2002, Physiology & Behavior.
[20] C. Patlak,et al. Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.
[21] O. Blin,et al. Dopaminergic Contribution to the Regulation of Emotional Perception , 2005, Clinical neuropharmacology.
[22] A. Gjedde,et al. Enhanced [3H]DOPA and [3H]Dopamine Turnover in Striatum and Frontal Cortex In Vivo Linked to Glutamate Receptor Antagonism , 1998, Journal of neurochemistry.
[23] Paul Cumming,et al. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. , 2005, The American journal of psychiatry.
[24] H. Baker,et al. Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings , 1979, British Journal of Psychiatry.
[25] A Reilhac,et al. Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease , 2004, Acta neurologica Scandinavica.
[26] R. Rimón,et al. The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia. , 1971, Journal of psychosomatic research.
[27] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] V Sossi,et al. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] J. Hietala,et al. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia , 1999, Schizophrenia Research.
[30] Albert Gjedde,et al. Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo , 2003, Neuropsychopharmacology.
[31] Albert Gjedde,et al. High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain , 1981, Journal of neurochemistry.
[32] Albert Gjedde,et al. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examination , 1982, Brain Research Reviews.
[33] Andrew D. Roberts,et al. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa , 1999, Neurology.
[34] V Sossi,et al. A Reversible Tracer Analysis Approach to the Study of Effective Dopamine Turnover , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] Bradley T. Christian,et al. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia , 2006, Schizophrenia Research.
[36] A. Meyer-Lindenberg,et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia , 2002, Nature Neuroscience.
[37] M. Laruelle,et al. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies , 1999, Journal of psychopharmacology.
[38] N. Andreasen,et al. Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders. , 1995, American journal of medical genetics.
[39] A. Gjedde,et al. Pharmacokinetics of Plasma 6-[18F]Fluoro-l-3,4-Dihydroxyphenylalanine ([18F]FDOPA) in Humans , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] A. Gjedde,et al. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo , 1997, Journal of Neuroscience Methods.
[41] Hans-Georg Buchholz,et al. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge , 2006, NeuroImage.
[42] K. Davis,et al. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. , 1988, Archives of general psychiatry.
[43] A. Lawrence,et al. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. , 2004, Archives of general psychiatry.
[44] J. Krystal,et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. , 1998, The American journal of psychiatry.
[45] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] G. Sedvall,et al. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. , 1980, Archives of general psychiatry.
[47] M. Bergström,et al. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET , 1999, Biological Psychiatry.
[48] Paul Cumming,et al. The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat , 1997, Brain Research.
[49] J. Fudge,et al. The extended amygdala and the dopamine system: another piece of the dopamine puzzle. , 2003, The Journal of neuropsychiatry and clinical neurosciences.
[50] R. Koeppe,et al. In Vivo Measurement of the Vesicular Monoamine Transporter in Schizophrenia , 2000, Neuropsychopharmacology.
[51] J. Krystal,et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[52] H. Tuckwell,et al. A meta-analysis of homovanillic acid concentrations in schizophrenia. , 1993, The International journal of neuroscience.
[53] A. Gjedde,et al. Cerebral 6‐[18F]fluoro‐L‐DOPA (FDOPA) metabolism in pig studied by positron emission tomography , 1999 .
[54] A. Carlsson,et al. Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. , 2003, Scandinavian journal of psychology.
[55] A. Gjedde,et al. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography. , 1999, Synapse.